Skip to main content

Winston Wong, PharmD

Editor's Page
03/14/2019
Continued innovations in oncology hold the promise of survival improvements. However, new treatments introduce significant challenges for patients, such as higher out-of-pocket expenses and new toxicities. Likewise,...
Continued innovations in oncology hold the promise of survival improvements. However, new treatments introduce significant challenges for patients, such as higher out-of-pocket expenses and new toxicities. Likewise,...
...
03/14/2019
Journal of Clinical Pathways
Editor's Page
04/11/2017
Patients are entitled to the best possible health care at the lowest possible cost. Clinical pathways have served to promote evidence-based medicine and value-based care across the medical continuum. The quality of...
Patients are entitled to the best possible health care at the lowest possible cost. Clinical pathways have served to promote evidence-based medicine and value-based care across the medical continuum. The quality of...
...
04/11/2017
Journal of Clinical Pathways
Editor's Page
02/06/2023
Editor-in-Chief, Winston Wong, PharmD, outlines the Global Use of Medicines 2023 report on the next 5 years of medical spending and how the health care industry must continue to improve efficiency and quality, informed by evidence-based...
Editor-in-Chief, Winston Wong, PharmD, outlines the Global Use of Medicines 2023 report on the next 5 years of medical spending and how the health care industry must continue to improve efficiency and quality, informed by evidence-based...
Editor-in-Chief, Winston Wong,...
02/06/2023
Journal of Clinical Pathways
Viewpoint
04/17/2018
The ability to rewire human immune systems to fight cancer is certainly an exciting prospect. With the first 2 chimeric antigen receptor T-cell (CAR-T) therapies approved and over 200 more in clinical trials,...
The ability to rewire human immune systems to fight cancer is certainly an exciting prospect. With the first 2 chimeric antigen receptor T-cell (CAR-T) therapies approved and over 200 more in clinical trials,...
The...
04/17/2018
Journal of Clinical Pathways
Care Delivery and Collaboration in the  Real World
Editor's Page
08/19/2020
While randomized trials are the gold standard in research, the need for real-world data is eminent. Real-world data can generate insights from routine health care and close the gap between research and routine...
While randomized trials are the gold standard in research, the need for real-world data is eminent. Real-world data can generate insights from routine health care and close the gap between research and routine...
While...
08/19/2020
Journal of Clinical Pathways
Editor Insights
03/05/2018
Clinical pathways may require a deeper consideration of the patient experience in order to achieve the goals of the Triple Aim, according to Winston Wong, PharmD.
Clinical pathways may require a deeper consideration of the patient experience in order to achieve the goals of the Triple Aim, according to Winston Wong, PharmD.
Clinical pathways may require a...
03/05/2018
Journal of Clinical Pathways
Review
09/19/2023
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon...
09/19/2023
Journal of Clinical Pathways
Editor's Page
12/13/2018
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the...
12/13/2018
Journal of Clinical Pathways
Editor's Page
04/17/2018
It is an exciting time in oncology care as innovative cellular and gene therapies come to market, with many more to come in the near future. While the promise of these therapies is certainly cause for enthusiasm,...
It is an exciting time in oncology care as innovative cellular and gene therapies come to market, with many more to come in the near future. While the promise of these therapies is certainly cause for enthusiasm,...
It is...
04/17/2018
Journal of Clinical Pathways
Editor's Page
10/27/2015
We are excited to bring to you Journal of Clinical Pathways, which will serve as a forum for the exciting exchange of data, research, insights, and perspectives that will shape the foundation of value-based care.
We are excited to bring to you Journal of Clinical Pathways, which will serve as a forum for the exciting exchange of data, research, insights, and perspectives that will shape the foundation of value-based care.
We are excited to bring to you...
10/27/2015
Journal of Clinical Pathways